DUBLIN--(BUSINESS WIRE)--The "Global Permanent Artificial Skin Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
The permanent artificial skin market will register a CAGR of almost 19% by 2023.
Increasing initiatives to raise awareness of skin and tissue donation to drive market growth
Organizations such as Donate Life America are conducting an increasing number of awareness programs to increase the awareness of skin ailments that require replacement surgeries and the need for skin donation. Donate Life America is a non-profit organization that promotes the donation of organs, eyes, and tissue.
The organization partners with other organizations such as the American Association of Tissue Banks to educate the population across the US about tissue donation and encourage people to donate tissue.
Availability of cost-effective treatment in developing countries
The global permanent artificial skin market is not regulated in developing countries in South America and APAC. The high availability of certified doctors and the low cost of treatment is driving the growth of permanent artificial skin market in these regions.
Countries such as China, India, Brazil, and South Korea are among the top 10 countries in the world in terms of the number of certified cosmetic surgeons.
Lack of accessibility and affordability of diagnostic test centers
Advanced diagnostic centers that offer a wide range of diagnostic tests are widely present in developing countries. However, there is a shortage of such centers in developing countries, where the disease burden is high. As a result, numerous patients with chronic diseases remain undiagnosed due to the lack of availability of diagnostic centers.
Competitive Landscape
The market appears to be fragmented, and with the presence of several companies including MiMedx and Solsys Medical, the competitive environment is quite intense.
Key Players
- Avita Medical
- Eucare Pharmaceuticals
- Integra LifeSciences
- MiMedx
- Solsys Medical
Topics Covered
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY END-USER
- Comparison by end-user
- Hospitals - Market size and forecast 2018-2023
- Other healthcare centers - Market size and forecast 2018-2023
- Market opportunity by end-user
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- APAC - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
- Technological advances
- Strategic alliances
- Increasing initiatives to raise awareness of skin and tissue donation
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Avita Medical
- Eucare Pharmaceuticals
- Integra LifeSciences
- MiMedx
- Solsys Medical
For more information about this report visit https://www.researchandmarkets.com/research/ltmjq2/worldwide?w=4
